These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 36930148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Zhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q, Zhang JF, Li ZB, Yang SY, Li XJ, Li XY.
    JAMA Intern Med; 2016 Aug 01; 176(8):1074-82. PubMed ID: 27379904
    [Abstract] [Full Text] [Related]

  • 3. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial.
    Pavlou V, Cienfuegos S, Lin S, Ezpeleta M, Ready K, Corapi S, Wu J, Lopez J, Gabel K, Tussing-Humphreys L, Oddo VM, Alexandria SJ, Sanchez J, Unterman T, Chow LS, Vidmar AP, Varady KA.
    JAMA Netw Open; 2023 Oct 02; 6(10):e2339337. PubMed ID: 37889487
    [Abstract] [Full Text] [Related]

  • 4. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial.
    Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ.
    JAMA Intern Med; 2020 Nov 01; 180(11):1491-1499. PubMed ID: 32986097
    [Abstract] [Full Text] [Related]

  • 5. Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study.
    Xu Q, Zhang J, Han H, Chen N, Lai F, Liu Y, Huang C, Lin M, Zhang W, Wang S, Liu C, Li Z.
    BMJ Open; 2022 Feb 21; 12(2):e057820. PubMed ID: 35190444
    [Abstract] [Full Text] [Related]

  • 6. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S.
    Gastroenterology; 2008 Feb 21; 134(2):424-31. PubMed ID: 18242210
    [Abstract] [Full Text] [Related]

  • 7. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
    Beals JW, Smith GI, Shankaran M, Fuchs A, Schweitzer GG, Yoshino J, Field T, Matthews M, Nyangau E, Morozov D, Mittendorfer B, Hellerstein MK, Klein S.
    Hepatology; 2021 Sep 21; 74(3):1287-1299. PubMed ID: 33743554
    [Abstract] [Full Text] [Related]

  • 8. Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study.
    Pan LL, Zhang HJ, Huang ZF, Sun Q, Chen Z, Li ZB, Yang SY, Li XY, Li XJ.
    Metabolism; 2015 Sep 21; 64(9):1077-85. PubMed ID: 26144271
    [Abstract] [Full Text] [Related]

  • 9. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
    Liu Z, Jin P, Liu Y, Zhang Z, Wu X, Weng M, Cao S, Wang Y, Zeng C, Yang R, Liu C, Sun P, Tian C, Li N, Zeng Q.
    Nutr J; 2024 Jun 13; 23(1):64. PubMed ID: 38872173
    [Abstract] [Full Text] [Related]

  • 10. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW, Chan RS, Wong GL, Cheung BH, Chu WC, Yeung DK, Chim AM, Lai JW, Li LS, Sea MM, Chan FK, Sung JJ, Woo J, Chan HL.
    J Hepatol; 2013 Sep 13; 59(3):536-42. PubMed ID: 23623998
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial.
    Jamshed H, Steger FL, Bryan DR, Richman JS, Warriner AH, Hanick CJ, Martin CK, Salvy SJ, Peterson CM.
    JAMA Intern Med; 2022 Sep 01; 182(9):953-962. PubMed ID: 35939311
    [Abstract] [Full Text] [Related]

  • 12. The effects of time-restricted eating for patients with nonalcoholic fatty liver disease: a systematic review.
    Lin X, Wang S, Huang J.
    Front Nutr; 2023 Sep 01; 10():1307736. PubMed ID: 38239843
    [Abstract] [Full Text] [Related]

  • 13. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, Klein S.
    J Clin Endocrinol Metab; 2010 Jun 01; 95(6):2727-35. PubMed ID: 20371660
    [Abstract] [Full Text] [Related]

  • 14. Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Lee HA, Moon H, Kim Y, Lee HA, Kim HY.
    Trials; 2023 Aug 02; 24(1):490. PubMed ID: 37533096
    [Abstract] [Full Text] [Related]

  • 15. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
    Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S.
    Obesity (Silver Spring); 2009 Jan 02; 17(1):25-9. PubMed ID: 18948971
    [Abstract] [Full Text] [Related]

  • 16. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.
    Zhang HJ, Pan LL, Ma ZM, Chen Z, Huang ZF, Sun Q, Lu Y, Han CK, Lin MZ, Li XJ, Yang SY, Li XY.
    Diabetes Obes Metab; 2017 Feb 02; 19(2):284-289. PubMed ID: 27761987
    [Abstract] [Full Text] [Related]

  • 17. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F, Barb D, Portillo-Sanchez P, Biernacki D, Lomonaco R, Suman A, Weber MH, Budd JT, Lupi ME, Cusi K.
    Hepatology; 2017 Apr 02; 65(4):1132-1144. PubMed ID: 27981615
    [Abstract] [Full Text] [Related]

  • 18. Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity : A Randomized Controlled Trial.
    Maruthur NM, Pilla SJ, White K, Wu B, Maw MTT, Duan D, Turkson-Ocran RA, Zhao D, Charleston J, Peterson CM, Dougherty RJ, Schrack JA, Appel LJ, Guallar E, Clark JM.
    Ann Intern Med; 2024 May 02; 177(5):549-558. PubMed ID: 38639542
    [Abstract] [Full Text] [Related]

  • 19. Dose-response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease.
    Xiao F, Shi X, Huang P, Zeng X, Wang L, Zeng J, Liu C, Yan B, Song H, Xu Y, Han L, Zhao Q, Lin M, Li X.
    Diabetes Metab; 2021 Nov 02; 47(6):101221. PubMed ID: 33373666
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
    Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S.
    Hepatology; 2012 Jun 02; 55(6):1738-45. PubMed ID: 22213436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.